Cardinal Health Shares Drop Despite Raised Outlook and $1.9B Solaris Deal
Cardinal Health, Inc. (NYSE: CAH) saw its shares decline 6.61% to $147.24 following a Q2 CY2025 revenue miss, despite raising its full-year EPS guidance. The healthcare services giant reported flat revenue of $60.16 billion, falling short of Wall Street's $60.75 billion estimate. Adjusted earnings per share of $2.08 narrowly beat expectations, driven by a 19% increase in non-GAAP operating earnings.
The company announced a $1.9 billion acquisition of Solaris Health to expand its specialty care network, signaling a strategic pivot toward higher-margin services. While the loss of a major OptumRx contract weighed on results, double-digit profit growth across all segments and raised FY2026 guidance ($9.30–$9.50 EPS) suggest underlying operational strength.
